Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease: Results from a cross-sectional study

Background: Decreased hippocampal volume is a biomarker of Alzheimer disease (AD). The association of hippocampal volume with gait variability across the spectrum of AD, especially in early stages, has been few studied. The study aims to examine the association of hippocampal volume with the coefficient of variation (CoV) of stride time in individuals with mild and moderate to severe subjective cognitive impairment (SCI), non‐amnestic mild cognitive impairment (na‐MCI), amnestic mild cognitive impairment (a‐MCI), and mild to moderate AD dementia. Methods: 271 individuals (79 mild SCI, 68 moderate to severe SCI, 47 na‐MCI, 42 a‐MCI and 35 mild to moderate AD dementia) were included in this cross‐sectional study. Hippocampal volume was quantified from a three‐dimensional T1‐weighted MRI. CoV of stride time was recorded at self‐selected pace with an electronic walkway. Age, sex, body mass index, number of drugs daily taken, history of falls, walking speed, type of MRI scanner, total intracranial volume, and white matter volume abnormality were used as covariates. Results: Participants with moderate to severe SCI had a higher CoV of stride time compared to those with mild SCI and na‐MCI (P < 0.010), and a higher hippocampal volume compared to other groups (P ≤ 0.001). Participants with moderate to severe SCI had increased hippocampal volume associated with increased CoV of stride time (coefficient of regression &bgr; = 0.750 with P = 0.041), while the other groups did not show any significant association. Conclusions: A positive association between greater hippocampal volume (i.e., better brain morphological structure) and an increased stride time variability (i.e., worse gait performance) in individuals with moderate to severe SCI is reported. This association confirms the key role of the hippocampus in gait control and suggests an inefficient compensatory mechanism in early stages of pathological aging like AD.

[1]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[2]  Mony J. de Leon,et al.  Subjective Memory Complaints: Presence, Severity and Future Outcome in Normal Older Subjects , 2007, Dementia and Geriatric Cognitive Disorders.

[3]  O. Beauchet,et al.  Subjective Memory Impairment and Gait Variability in Cognitively Healthy Individuals: Results from a Cross-Sectional Pilot Study. , 2016, Journal of Alzheimer's disease : JAD.

[4]  Bradford C. Dickerson,et al.  Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies , 2008, Neuropsychologia.

[5]  C. Neuringer,et al.  Trial making test as a screening device for the detection of brain damage. , 1958, Journal of consulting psychology.

[6]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[7]  I Litvan,et al.  The FAB: A frontal assessment battery at bedside , 2000, Neurology.

[8]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[9]  U. Nayak,et al.  The effect of age on variability in gait. , 1984, Journal of gerontology.

[10]  Nick C Fox,et al.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.

[11]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[12]  Andrew J. Saykin,et al.  A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease , 2014, Alzheimer's & Dementia.

[13]  Neal Jeffries,et al.  Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. , 2003, Brain : a journal of neurology.

[14]  Cédric Annweiler,et al.  Gait Variability among Healthy Adults: Low and High Stride-to-Stride Variability Are Both a Reflection of Gait Stability , 2009, Gerontology.

[15]  S. Lehéricy,et al.  P2a-4 Etude Hippocampe : Evaluation de l’efficacité du donépézil versus placebo sur des marqueurs IRM et cliniques chez des patients présentant des troubles cognitifs légers , 2009 .

[16]  C. Annweiler,et al.  Gait variability at fast-pace walking speed: A biomarker of mild cognitive impairment? , 2013, The journal of nutrition, health & aging.

[17]  Philip B. Ward,et al.  Effect of aerobic exercise on hippocampal volume in humans: A systematic review and meta-analysis , 2018, NeuroImage.

[18]  C. Dufouil,et al.  Subjective Cognitive Complaints and Cognitive Decline: Consequence or Predictor? The Epidemiology of Vascular Aging Study , 2005, Journal of the American Geriatrics Society.

[19]  H. Buschke,et al.  Screening for dementia by memory testing , 1988, Neurology.

[20]  Tamara B Harris,et al.  Higher step length variability indicates lower gray matter integrity of selected regions in older adults. , 2014, Gait & posture.

[21]  R. Mahendran,et al.  Screening for depression among acutely ill geriatric inpatients with a short Geriatric Depression Scale. , 1997, Age and ageing.

[22]  Martial Van der Linden,et al.  L'épreuve de rappel libre / rappel indicé à 16 items (RL/RI-16) , 2004 .

[23]  C. Annweiler,et al.  Gait phenotype from mild cognitive impairment to moderate dementia: results from the GOOD initiative , 2016, European journal of neurology.

[24]  Nick C Fox,et al.  Revising the definition of Alzheimer's disease: a new lexicon , 2010, The Lancet Neurology.

[25]  Keiichi Oda,et al.  Gait adaptability and brain activity during unaccustomed treadmill walking in healthy elderly females. , 2013, Gait & posture.

[26]  C. Annweiler,et al.  Hippocampal volume, early cognitive decline and gait variability: Which association? , 2015, Experimental Gerontology.

[27]  Sterling C. Johnson,et al.  Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-age adults at risk of AD , 2015, Alzheimer's & dementia.

[28]  C. Jack,et al.  Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor‐based morphometry , 2010, Human brain mapping.

[29]  Joseph T. Gwin,et al.  Motor control and aging: Links to age-related brain structural, functional, and biochemical effects , 2010, Neuroscience & Biobehavioral Reviews.

[30]  Tony Szturm,et al.  Guidelines for Assessment of Gait and Reference Values for Spatiotemporal Gait Parameters in Older Adults: The Biomathics and Canadian Gait Consortiums Initiative , 2017, Front. Hum. Neurosci..

[31]  Victoria J. Williams,et al.  Association between white matter microstructure, executive functions, and processing speed in older adults: The impact of vascular health , 2013, Human brain mapping.

[32]  O. Beauchet,et al.  How to manage recurrent falls in clinical practice: Guidelines of the French society of geriatrics and gerontology , 2010 .

[33]  Theo Mulder,et al.  Gait in ageing and associated dementias; its relationship with cognition , 2007, Neuroscience & Biobehavioral Reviews.

[34]  Richard S. J. Frackowiak,et al.  Navigation-related structural change in the hippocampi of taxi drivers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[36]  C. Fabrigoule,et al.  Restriction in complex activities of daily living in MCI , 2006, Neurology.

[37]  Jullie W Pan,et al.  MRI- and MRS-derived hippocampal correlates of quantitative locomotor function in older adults , 2009, Brain Research.